Pacific Crest said weakness in Lam Resarch (LRCX) related to a competitor note on that Samsung postponed DRAM equipment orders is overdone. The firm said Samsung wasn't doing anything with its Line-17 Phase 2 this year and hasn't even really discussed plans. Pacific Crest views the competitor commentary as convoluted and would aggressively buy Lam Research.
Check out this evening's top movers from around Wall Street, compiled by The Fly. HIGHER AFTER EARNINGSImpinj (PI) up... To see the rest of the story go to thefly.com. See Story Here